Baxalta Company Profile (NASDAQ:BXLT)

Analyst Ratings

Consensus Ratings for Baxalta (NASDAQ:BXLT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Baxalta (NASDAQ:BXLT)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Baxalta (NASDAQ:BXLT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Baxalta (NASDAQ:BXLT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.46$0.46$0.46
Q2 20161$0.53$0.53$0.53
Q3 20161$0.56$0.56$0.56
Q4 20161$0.62$0.62$0.62
Q1 20171$0.53$0.53$0.53
Q2 20171$0.58$0.58$0.58
Q3 20171$0.61$0.61$0.61
Q4 20171$0.69$0.69$0.69
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Baxalta (NASDAQ:BXLT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/10/2016Quarterly$0.076/8/20166/10/20167/1/2016Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Baxalta (NASDAQ:BXLT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Baxalta (NASDAQ:BXLT)
DateHeadline
05/24/16 02:02 PMHealthcare News Buzz: Valeant Pharmaceuticals Intl Inc(NYSE:VRX), Baxalta Inc (NYSE:BXLT) - NYSE Journal (press release) - Healthcare News Buzz: Valeant Pharmaceuticals Intl Inc(NYSE:VRX), Baxalta Inc (NYSE:BXLT)NYSE Journal (press release)On Monday, Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), subtract -4.59% and closed at $26.21 in the last trading session. The last trading range of the stock ranges between $26.11 and $27.67. Valeant Pharmaceuticals International, Inc. (VRX) ...and more »
05/24/16 02:02 PMBaxalta Inc (NYSE:BXLT) & CVS Health Corp (NYSE:CVS) Healthcare Stock's Buzzers - Wall Street 24 - Baxalta Inc (NYSE:BXLT) & CVS Health Corp (NYSE:CVS) Healthcare Stock's BuzzersWall Street 24On Monday, Shares of Baxalta Inc (NYSE:BXLT) gained 0.41% to $44.61. The share price is trading in a range of $44.45 – $45.11. The stock exchanged hands with 10.16 Million shares contrast to its average daily volume of 8.70 Million shares. Baxalta ...and more »
05/14/16 12:04 PMBAXALTA INC Financials -
05/13/16 01:41 PMShort Sellers Dump Amgen And Baxalta - Benzinga - BenzingaShort Sellers Dump Amgen And BaxaltaBenzingaAmgen, Inc. AMGN and Baxalta Inc BXLT in particular saw double-digit percentage declines in the number of their shares short, in a period in which the former posted better-than-expected first-quarter results, and the acquisition of the latter by Shire ...
05/13/16 07:56 AMShort Sellers Dump Amgen And Baxalta -
05/10/16 05:00 PMBRIEF-Baxalta Inc sets quarterly cash dividend of $0.07 per share - * Special meeting of stockholders to adopt merger agreement with Shire Plc will be held on May 27, 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
05/09/16 01:05 PMAs Shire-Baxalta merger nears, lots of unanswered questions remain -
05/04/16 01:26 PMStock's Earnings Analysis: Baxalta Inc (NYSE:BXLT) - News Oracle - Stock's Earnings Analysis: Baxalta Inc (NYSE:BXLT)News OracleLast Trade: The Company rose 0.38% and finished at $42.30. The daily volume was measured at 11.16 million shares. The 52-week high of the share price is $42.85 and the 52-week low is $29.83. The company has a market cap of $28.95 Billion. The stock ...and more »
05/04/16 01:26 PMBiotech Stock to Lookout: Baxalta Inc (NYSE:BXLT), Gilead Sciences, Inc. (NASDAQ:GILD), Medivation Inc (NASDAQ ... - The Point Review - The Point ReviewBiotech Stock to Lookout: Baxalta Inc (NYSE:BXLT), Gilead Sciences, Inc. (NASDAQ:GILD), Medivation Inc (NASDAQ ...The Point ReviewShares of Baxalta Inc (NYSE:BXLT) fell -1.42% to $41.70 at 12:30 PM EDT. The stock attained the volume of 4.23 Million shares recently versus average trading volume of 9.89 Million shares. If we take a look on its volatility, 2.28 percent was seen in a ...and more »
05/03/16 01:39 PMHC Stocks Highlights: Medivation Inc (MDVN), Teva Pharmaceutical Industries Ltd (TEVA), Baxalta Inc (BXLT) - share market updates (press release) - share market updates (press release)HC Stocks Highlights: Medivation Inc (MDVN), Teva Pharmaceutical Industries Ltd (TEVA), Baxalta Inc (BXLT)share market updates (press release)Shares of Medivation Inc (NASDAQ:MDVN) ended Monday session in green amid volatile trading. The shares closed up +0.21 points or 0.36% at $58.01 with 3,511,446 shares getting traded. Post opening the session at $57.48, the shares hit an intraday low ...and more »
05/03/16 01:39 PMAllergan plc Ordinary Shares (NYSE:AGN) & Baxalta Inc (NYSE:BXLT) Stocks Alert - Wall Street 24 - Allergan plc Ordinary Shares (NYSE:AGN) & Baxalta Inc (NYSE:BXLT) Stocks AlertWall Street 24On Monday, Shares of Allergan plc Ordinary Shares (NYSE:AGN) gained 0.72% to $218.11. The share price is trading in a range of $216.02 – $220.35. The stock exchanged hands with 3.11 Million shares contrast to its average daily volume of 6.61 Million ...and more »
05/03/16 01:39 PMTwo Biotech stocks to Watch: Baxalta Incorporated (NYSE:BXLT) , ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) - Is stories - Two Biotech stocks to Watch: Baxalta Incorporated (NYSE:BXLT) , ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)Is storiesBaxalta Incorporated (NYSE:BXLT) increased +0.45% to $42.14 while traded 10.15 million shares on 5/2/2016. The stock price negotiated for value between $41.92 to $42.68 in recent trading session. During the past 52 weeks, the stock's price witnessed a ...Stocks to Track: Baxalta Incorporated (BXLT), Pepsico (PEP), General Electric (GE)iStreetWireall 3 news articles »
05/03/16 09:27 AMBiogen Spinning Off Hemophilia Business As Competition Heats Up -
05/03/16 09:01 AMBaxalta, Inc. :BXLT-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/29/16 01:43 PMCurrent Trade Roundup: Baxalta Inc (BXLT), NXP Semiconductors NV (NXPI) - News Oracle - Current Trade Roundup: Baxalta Inc (BXLT), NXP Semiconductors NV (NXPI)News OracleBaxalta Inc (NYSE:BXLT) is trading up with a percentage change of 2.47% and is at $41.90 right now. The Company's market capitalization stands at $28.60 Billion in the current trading Session whereas, its outstanding shares are 681.24 Million.
04/29/16 01:43 PMEarnings Recap: Baxalta Inc (NYSE:BXLT) - The Point Review - The Point ReviewEarnings Recap: Baxalta Inc (NYSE:BXLT)The Point ReviewIn the first quarter, Baxalta generated net income on a GAAP basis of $145 million and earnings of $0.21 per diluted share. These results include net after-tax special items totaling $181 million, or $0.26 per diluted share, primarily for intangible ...Lincluden Management Ltd Exits Position in Baxalta Inc (BXLT)Market DigestStocks update: UnitedHealth Group Inc (UNH), Baxalta Inc (BXLT)News OracleBaxalta Inc (NYSE:BXLT) Consensus Recommendation UpdateNews TribuneZergwatch -Web Breaking News -Wall Street 24all 40 news articles »
04/29/16 07:48 AMShire jumps as Vyvanse drug helps it to beat earnings forecast - [Reuters - UK Focus] - Strong demand for Shire (Xetra: S7E.DE - news) 's top-selling Vyvanse drug helped to lift first-quarter earnings by a better than expected 12 percent, boosting the London-listed group's shares ahead of its $32 billion acquisition of U.S (Other OTC: UBGXF - news) . Sales of Vyvanse, a treatment for attention deficit hyperactivity disorder (ADHD), rose 22 percent, partly reflecting the drug's recent approval as a treatment for binge eating disorder (BED). "Shire is off to a strong start in 2016," said Chief Executive Flemming Ornskov, who has faced investor criticisms over his pay.
04/29/16 07:47 AM[$$] Shire Posts First-Quarter Profit, Revenue Growth -
04/28/16 10:41 AMBaxalta (BXLT) Beats on Q1 Earnings, Set to Merge with Shire -
04/28/16 09:48 AMBaxalta (BXLT) Beats on Q1 Earnings, Revenues Rise Y/Y -
04/28/16 08:38 AM[$$] Shire Shareholders Rebel Over CEO Pay -
04/28/16 08:30 AMThe Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and Shire -
04/28/16 07:37 AMBaxalta posts 1Q profit -
04/28/16 07:34 AMShort Sellers Dump Vertex, Load Up On Baxalta -
04/20/16 01:50 PMHC Stocks Vigilant: Baxalta Inc (BXLT), Ionis Pharmaceuticals Inc (IONS), Quintiles Transnational Holdings Inc (Q) - share market updates (press release) - share market updates (press release)HC Stocks Vigilant: Baxalta Inc (BXLT), Ionis Pharmaceuticals Inc (IONS), Quintiles Transnational Holdings Inc (Q)share market updates (press release)Shares of Baxalta Inc (NYSE:BXLT) ended Tuesday session in red amid volatile trading. The shares closed down -0.08 points or -0.19% at $41.26 with 7,307,241 shares getting traded. Post opening the session at $41.29, the shares hit an intraday low of ...and more »
04/20/16 09:07 AMWhy BioMarin is Soaring -
04/19/16 01:51 PMAnalysts Observing Recap: Skyline Medical Inc. (NASDAQ:SKLN) , Baxalta Incorporated (_ - Street Updates - Analysts Observing Recap: Skyline Medical Inc. (NASDAQ:SKLN) , Baxalta Incorporated (_Street UpdatesBaxalta Incorporated (NYSE:BXLT) after beginning at $40.55, closed at $41.34 by building up +2.05% in recent trading session. Most recent session's volume of 5.35 million shares lower than its average volume of 9.4 million shares. The company has ...
04/18/16 01:58 PMCheck on Stock Rating Baxalta Inc (NYSE:BXLT) - Business Standard Tribune - Check on Stock Rating Baxalta Inc (NYSE:BXLT)Business Standard TribuneBaxalta Inc (NYSE:BXLT) currently has a rating of 2 on shares. On a scale from 1 to 5, a rating of 1 or 2 would represent a Buy. On the same scale, a stock rating of 4 or 5 would represent a Sell. A rating of 3 would represent a Hold. This consensus ...and more »
04/16/16 01:10 PMCVS Health (NYSE:CVS) & Baxalta Inc (NYSE:BXLT) Stocks in the News - Wall Street 24 - CVS Health (NYSE:CVS) & Baxalta Inc (NYSE:BXLT) Stocks in the NewsWall Street 24On Thursday, Shares of CVS Health Corp (NYSE:CVS) lost -0.04% to $101.09. The share price is trading in a range of $100.86 – $101.62. The stock exchanged hands with 3.38 Million shares contrast to its average daily volume of 4.05 Million shares.and more »
04/16/16 01:10 PMBaxalta Inc (NYSE:BXLT) Ratios & Valuation in Focus - Orygun Business News - Baxalta Inc (NYSE:BXLT) Ratios & Valuation in FocusOrygun Business NewsBaxalta Inc (NYSE:BXLT) of the Medical sector is a highly scrutinized stock when is comes to the firm's valuation and earnings projections. Using the current price over mean EPS estimate before non-recurring items for the fiscal year, the shares have a ...
04/16/16 01:10 PMLvm Capital Management Ltdmi Lowers stake in Baxalta Inc (BXLT) - Market Digest - Lvm Capital Management Ltdmi Lowers stake in Baxalta Inc (BXLT)Market DigestBaxalta Inc (BXLT) : Lvm Capital Management Ltdmi reduced its stake in Baxalta Inc by 15.91% during the most recent quarter end. The investment management company now holds a total of 8,325 shares of Baxalta Inc which is valued at $335,914 after ...and more »
04/16/16 01:10 PMTwo Movers inside Analysts Radar: Baxalta Incorporated (NYSE:BXLT) , Aetna Inc. (NYSE:AET) - Street Updates - Two Movers inside Analysts Radar: Baxalta Incorporated (NYSE:BXLT) , Aetna Inc. (NYSE:AET)Street UpdatesIt has return on equity (ROE) of 21.20 % and while returns on investment (ROI) was measured at 10.10 %. Baxalta Incorporated (BXLT) reported that the special meeting of stockholders to adopt the merger contract with Shire plc (LSE:SHP, NASDAQ:SHPG) ...and more »
04/16/16 01:10 PMEarnings Watch on Baxalta Inc (NYSE:BXLT) - RiversideGazette.com - Earnings Watch on Baxalta Inc (NYSE:BXLT)RiversideGazette.comBaxalta Inc (NYSE:BXLT) has a consensus earnings per share estimate for the current quarter of $0.46 based on compiled analyst projections. The company is next expected to release earnings on or around 2016-05-17 for the period ending 2016-03-31.and more »
04/14/16 01:50 PMHC Stocks Overview: AbbVie Inc (ABBV), Hologic Inc. (HOLX), Baxalta Inc (BXLT) - share market updates (press release) - HC Stocks Overview: AbbVie Inc (ABBV), Hologic Inc. (HOLX), Baxalta Inc (BXLT)share market updates (press release)Shares of AbbVie Inc (NYSE:ABBV) ended Wednesday session in red amid volatile trading. The shares closed down -0.27 points or -0.46% at $59.05 with 7.02 million shares getting traded. Post opening the session at $59.87, the shares hit an intraday low ...and more »
04/13/16 02:03 PMShares in Focus - Baxalta Inc (NYSE:BXLT) - Stock Caller - Shares in Focus - Baxalta Inc (NYSE:BXLT)Stock CallerBaxalta Inc (NYSE:BXLT) shares have been given a top rating from Beta Systems research. This rating considers fundamentals, potential future earnings growth and analyst opinions. This data also uses analyst target price and EPS predictions. Traders are ...and more »
04/12/16 01:42 PMBaxalta Inc (NYSE:BXLT) Analyst Recommendation Outlook - Clinton Financial - Baxalta Inc (NYSE:BXLT) Analyst Recommendation OutlookClinton FinancialThere are 2 analysts providing ratings for Baxalta Inc (NYSE:BXLT). 2 have given the stock a “Strong Buy”, 0 rate it a “Buy”, 2 are rating the stock a Hold, and 0 are recommending “Sell”. Every recommendation can be mapped to an integer based scale ...and more »
04/11/16 01:58 PM2 Best Healthcare sector Stocks: Exelixis (EXEL), Baxalta Inc (BXLT) - News Oracle - 2 Best Healthcare sector Stocks: Exelixis (EXEL), Baxalta Inc (BXLT)News OracleExelixis, Inc. (NASDAQ:EXEL) declined -0.23% yesterday and closed at $4.25. The company's market capitalization is at $976.54 Million with an average trading volume of 4.80 Million. The total number of Outstanding Shares Held by the company are 228.19 ...Two Biotech Stocks Are Just So Hot Right Now: Viking Therapeutics, Inc. (VKTX), Baxalta Incorporated (BXLT)Zergwatchall 2 news articles »
04/11/16 01:58 PMView on Ratings Baxalta Inc (NYSE:BXLT) - Business Standard Tribune - View on Ratings Baxalta Inc (NYSE:BXLT)Business Standard TribuneUsing a scale from 1 to 5, Baxalta Inc (NYSE:BXLT) has a rating of 2 on the stock. A score of 1 or 2 indicates a Buy rating, and a score of 4 or 5 indicates a Sell rating. A 3 would indicate a Hold. This consensus number is made up of covering analysts ...and more »
04/08/16 01:46 PMU.S. Stocks Alert: Sprint Corp (S), Baxalta Inc (BXLT) - News Oracle - News OracleU.S. Stocks Alert: Sprint Corp (S), Baxalta Inc (BXLT)News OracleSprint Corp (NYSE:S) is trading down with a percentage change of -0.28% and is at $3.50 right now. The Company's market capitalization stands at $13.59 Billion in the current trading Session whereas, its outstanding shares are 3.97 Billion. Recent ...and more »
04/08/16 01:46 PMHC Stocks Analysis: Baxalta (BXLT), Gilead Sciences (GILD), Endo International plc (ENDP) - share market updates (press release) - share market updates (press release)HC Stocks Analysis: Baxalta (BXLT), Gilead Sciences (GILD), Endo International plc (ENDP)share market updates (press release)Shares of Baxalta Inc (NYSE:BXLT) ended Thursday session in red amid volatile trading. The shares closed down -0.27 points or -0.66% at $40.38 with 15.65 million shares getting traded. Post opening the session at $40.50, the shares hit an intraday low ...and more »
04/08/16 01:46 PMAltrinsic Global Advisors buys $99.6 Million stake in Baxalta Inc (BXLT) - Street Edition - Altrinsic Global Advisors buys $99.6 Million stake in Baxalta Inc (BXLT)Street EditionBaxalta Inc (BXLT) : Altrinsic Global Advisors scooped up 175,752 additional shares in Baxalta Inc during the Q4 period, according to a recent disclosure to the SEC. The investment management firm now holds a total of 2,549,025 shares of Baxalta Inc ...
04/08/16 01:46 PMEarnings View for Baxalta Inc (NYSE:BXLT) - RiversideGazette.com - Earnings View for Baxalta Inc (NYSE:BXLT)RiversideGazette.comWall Street analysts have a current quarter EPS estimate of $0.46 on shares of Baxalta Inc (NYSE:BXLT). Analysts and investors will be looking ahead to the next company earnings report which is scheduled to be released on or around 2016-05-17 for the ...and more »
04/08/16 07:01 AMCongress Must Amend the Federal Reserve Act Before the Next Recession -
04/06/16 01:35 PMBaxalta Inc. (NYSE:BXLT) announced that the Ministry of Health, Labour and Welfare in Japan approved ADYNOVATE ... - Inside Trade - Baxalta Inc. (NYSE:BXLT) announced that the Ministry of Health, Labour and Welfare in Japan approved ADYNOVATE ...Inside TradeBaxalta Inc. (NYSE:BXLT) announced that the Ministry of Health, Labour and Welfare in Japan approved ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended circulating half-life recombinant Factor VIII (rFVIII) treatment, for patients ...
04/06/16 01:35 PMBaxalta Inc (NYSE:BXLT)'s Adynovate Receives Approval of Japanese Health Ministry - Journal Transcript - Baxalta Inc (NYSE:BXLT)'s Adynovate Receives Approval of Japanese Health MinistryJournal TranscriptBaxalta Inc (NYSE:BXLT) has announced that its drug, Adynovate, has received an approval from the Japanese ministry of health, labor and welfare, to be used in the treatment of hemophilia patients that are 12-years or older. The schedule for the drug ...
04/06/16 01:35 PMFusion Investment Group Exits Position in Baxalta Inc (BXLT) - Everything HUDSON - South Florida Hedge Fund ManagersFusion Investment Group Exits Position in Baxalta Inc (BXLT)Everything HUDSONBaxalta Inc (BXLT) : Fusion Investment Group has sold out all of its stake in Baxalta Inc during the Q4 period, according to the information disclosed to the SEC. The investment management company has sold out 76 shares of Baxalta Inc which is valued ...Mission Wealth Management Lowers stake in Baxalta Inc (BXLT)Los Angeles MirrorCoho Partners Ltd. Has $24487000 Position in Baxalta Inc (BXLT)South Florida Hedge Fund ManagersGlovista Investments adds Baxalta Inc (BXLT) to its portfolioSCSUCollegianNews Oracle -Street Updates -SmallCapWired.comall 18 news articles »
04/06/16 01:12 PMBill Ackman Hints Who Valeant’s Next CEO Will Be -
04/06/16 11:55 AMTake Advantage of Biotech's Bear Market Bounce (IBB, CELG) -
04/06/16 07:10 AMBaxalta, Inc. breached its 50 day moving average in a Bearish Manner : BXLT-US : April 6, 2016 -
04/05/16 01:03 PMBiotech Mid-day Movers: Baxalta Inc (NYSE:BXLT), Cytori Therapeutics Inc (NASDAQ:CYTX), Geron Corporation ... - The Point Review - Biotech Mid-day Movers: Baxalta Inc (NYSE:BXLT), Cytori Therapeutics Inc (NASDAQ:CYTX), Geron Corporation ...The Point ReviewBaxalta Inc (NYSE:BXLT) jumped 1.52% to reach at $41.44. The company has experienced volume of 3.24 million and trading in the range of $40.96 – $41.93 for the current session. The sell-side analysts are projecting earnings per share of $0.46 for the ...

Social

About Baxalta

Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BXLT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • P/E Ratio:
  • P/E Growth:
  • Market Cap: $
  • Current Year EPS Consensus Estimate: $2.19 EPS
  • Next Year EPS Consensus Estimate: $2.54 EPS
Additional Links:
Baxalta (NASDAQ:BXLT) Chart for Saturday, July, 30, 2016